Meloxicam/Rizatriptan

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Pharmaceutical compositions comprising meloxicam
- US 11617791 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
  17 件公开
- US 12128052 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2023
  US
  13 件公开
- US 12005118 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  CN
  US
  WO
  8 件公开
- EP 4467600 A3
  申请人: AXSOME THERAPEUTICS INC优先权: 2017
  CN
  EP
  WO
  7 件公开
- US 2024058354 A1
  申请人: AXSOME THERAPEUTICS INC优先权: 2023
  US
  6 件公开
- EP 3817722 A4
  申请人: AXSOME THERAPEUTICS INC优先权: 2018
  CN
  EP
  US
  WO
  4 件公开
- US 11185550 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2021
  US
  4 件公开
- US 12370196 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2023
  US
  4 件公开
- EP 3920909 A4
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  CN
  EP
  WO
  3 件公开
- EP 4132511 A4
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  CN
  EP
  WO
  3 件公开
- EP 4770647 A1
  申请人: AXSOME THERAPEUTICS INC优先权: 2023
  CN
  EP
  WO
  3 件公开
- EP 4780463 A1
  申请人: AXSOME THERAPEUTICS INC优先权: 2023
  CN
  EP
  WO
  3 件公开
- US 10821182 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  3 件公开
- US 10905693 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  3 件公开
- US 10933136 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  3 件公开
- US 10918722 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  3 件公开
- US 11617755 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
  3 件公开
- US 12485176 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
  3 件公开
- US 11998552 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  CN
  US
  2 件公开
- US 10561664 B1
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
  2 件公开
- US 10940153 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  2 件公开
- US 10933137 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  2 件公开
- US 11013805 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  2 件公开
- US 11013806 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  2 件公开
- US 11045549 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
  2 件公开
- US 11471465 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
  2 件公开
- US 11617756 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
  2 件公开
- US 12691123 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
  2 件公开
- US 10471014 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2018
  US
- US 10583088 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2018
  US
- US 10512692 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10512693 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10532101 B1
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10537642 B1
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10517950 B1
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10729696 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10722583 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10729697 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10729773 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10583144 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10653777 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10688185 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10695429 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10695430 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 10702602 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2019
  US
- US 11266657 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10729774 B1
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10758617 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10780165 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10821181 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10799588 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10758618 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10780166 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10894053 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 10987358 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 11110173 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 11219626 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2020
  US
- US 11207327 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2021
  US
- US 11510927 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2021
  US
- US 11433078 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2021
  US
- US 11433079 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2021
  US
- US 11607456 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 11602563 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 11738085 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 11801250 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 11806354 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 11712441 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 11759522 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 11865117 B2
  申请人: AXSOME THERAPEUTICS INC优先权: 2022
  US
- US 2024082254 A1
  申请人: AXSOME THERAPEUTICS INC优先权: 2023
  US
- WO 2025221509 A1
  申请人: AXSOME THERAPEUTICS INC优先权: 2024
  WO
- US 20260183401 A1
  申请人: AXSOME THERAPEUTICS INC优先权: 2025
  US
PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM AND RIZATRIPTAN
EP 3789016 A1申请人: AXSOME THERAPEUTICS INC优先权: 2017
CN
EP
US
6 件公开
Methods of treating migraines with a combination of a meloxicam and a rizatriptan
US 12544383 B1申请人: AXSOME THERAPEUTICS INC优先权: 2025
US
5 件公开
Combination treatment for migraine and other pain
US 10688102 B2申请人: AXSOME THERAPEUTICS INC优先权: 2019
US
PHARMACEUTICAL COMPOSITION CONTAINING COMBINATION OF MELOXICAM AND RIZATRIPTAN AND PROCESS OF PREPARATION THEREOF
US 20250134901 A1申请人: ALEMBIC PHARMACEUTICALS LTD优先权: 2021
US
ANTIMIGRAINE PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM AND RIZATRIPTAN
WO 2026128586 A1申请人: AXSOME THERAPEUTICS INC优先权: 2024
WO

药物

Meloxicam/Rizatriptan

专利

Pharmaceutical compositions comprising meloxicam